Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma
✍ Scribed by Steven C. Kao, Nico van Zandwijk, Peter Corte…
- Book ID
- 120913163
- Publisher
- Springer-Verlag
- Year
- 2013
- Tongue
- English
- Weight
- 333 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Promising results with trimodality therapy combining surgery, chemotherapy, and radiotherapy have been obtained in the management of patients with malignant pleural mesothelioma (MPM). However, the histologic subtype has to be taken into account because of its influence
## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo